This study presents a case report of a female patient with symptomatic refractory Trichomonas vaginalis infection who was not able to clear her infection with high-dose oral metronidazole, oral tinidazole, intra-vaginal zinc sulfate, intra-vaginal metronidazole, intra-vaginal tinidazole, and intra-vaginal boric acid. She was unable to tolerate intra-vaginal paromomycin. A combination of intravenous metronidazole, oral tinidazole liquid suspension, and intra-vaginal boric acid for 14 days subsequently achieved a complete symptomatic and laboratory cure.
Center for Disease Control and Prevention. 2015 Sexually transmitted diseases treatment guidelines, www.cdc.gov/std/tg2015/trichomoniasis.htm (2015, accessed 13 December 2017).
2.
Abdel-MagiedAAHammoudaMMMosbahAet al.
In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates. J Infect Chemother2017;
23: 230–233.
3.
ByunJMJeongDHKimYNet al.
Experience of successful treatment of patients with metronidazole-resistant Trichomonas vaginalis with zinc sulfate: a case series. Taiwan J Obstet Gynecol2015;
54: 617–620.
4.
HouangETAhmetZLawrenceAG.Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy. Sex Transm Dis1997;
24: 116–119.
5.
NyirjesyPSobelJDWeitzMVet al.
Difficult to treat trichomonas: results with paromomycin cream. Clin Infect Dis1998;
26: 986–988.
6.
MuznyCBarnesAMenaL.Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid. Sex Health2012;
9: 389–391.
7.
HawkinsICarneCSonnexCet al.
Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole. Int J STD AIDS2015;
26: 676–678.
SenaACBachmannLHHobbsMM.Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Expert Rev Anti Infect Ther2014;
12: 673–685.
10.
KirkcaldyRDAugostiniPAsbelLEet al.
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis2012;
18: 939–943.
11.
SchwebkeJRBarrientesFJ.Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother2006;
50: 4209–4210.
12.
BossermanEAHelmsDJMosureDJet al.
Utility of antimicrobial susceptibility testing in Trichomonas vaginalis infected women with clinical treatment failure. Sex Transm Dis2011;
15: 248–249.
13.
MeitesEGaydosCAHobbsMMet al.
A review of evidence based care of symptomatic trichomoniasis and asymptomatic Trichomonas vaginalis infection. Clin Infect Dis2015;
61: S837–S848.